empacozatrio25&5&1000mg30tab

Empacozatrio is a triple-combination oral antidiabetic medication used to improve glycemic control in adults with type 2 diabetes mellitus. It combines Empagliflozin, Linagliptin, and Metformin hydrochloride. This formulation works through multiple mechanisms: Empagliflozin promotes glucose excretion via urine, Linagliptin enhances insulin secretion and reduces glucagon levels, and Metformin decreases hepatic glucose production and improves insulin sensitivity. This synergistic approach helps patients achieve better blood sugar management when diet and exercise alone are insufficient, or when patients are already stabilized on the individual components.